Efficiency of Methotrexate and Tofacitinib in Mild and Moderate Patients

Clinical trial NCT04299971 · UNKNOWN

Trial details

NCT number: NCT04299971
Sponsor: Shanghai Zhongshan Hospital
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Takayasu Arteritis Methotrexate Inhibition Treatment

Start date: 2020-03-01
Primary completion: 2022-12-31
Enrollment: 130

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.